KLF5 and liver cancer: In conclusion, we propose a model (Figure 7) in which p53 normally binds to miR-192 but where KLF5 can also bind to miR-192 when p53 binding is lost (as a result of p53 loss or mutation), which then transactivates miR-192 in place of p53 to suppress liver cancer cell EMT.